MannKind to Present at Aegis Capital Corp. 2015 Growth Conference

VALENCIA, Calif., Oct. 5, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it will present at the Aegis Capital Corp. 2015 Growth Conference on Thursday, October 8, 2015 at 9:30 am Pacific Time at the Encore at the Wynn Hotel in Las Vegas, Nevada.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at

About MannKind Corporation

MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

CONTACT: Company Contact: MannKind Corporation Matthew J. Pfeffer Corporate Vice President and Chief Financial Officer 661-775-5300

Source:MannKind Corporation